Results 141 to 150 of about 14,511 (164)

Antigenic Cross-Reactivity between Borrelia burgdorferi, Borrelia recurrentis, Treponema pallidum, and Treponema phagedenis

Zentralblatt für Bakteriologie, 1990
The antigenic cross-reactivity between different Borrelia and Treponema species was determined by the indirect immunofluorescence antibody test and sodium dodecyl sulphate-polyacrylamide gel electrophoresis followed by immunoblotting. The protein profiles of Borrelia burgdorferi, Borrelia recurrentis, Treponema pallidum, and Treponema phagedenis ...
B, Luther, M, Moskophidis
openaire   +2 more sources

Activation of protein mediators of inflammation and evidence for endotoxemia in Borrelia recurrentis infection

The American Journal of Medicine, 1977
Fifteen patients with Borrelia recurrentis infection were studied to evaluate the role of certain plasma proteins and endotoxin in the pathophysiology of both the acute illness and the Jarisch-Herxheimer-like reaction. The causative spirochetes disappeared from the blood during the Jarisch-Herxheimer-like reaction, which occurred about 2 hours after ...
R E, Galloway, J, Levin, T, Butler, G B, Naff, G H, Goldsmith, H, Saito, S, Awoke, C K, Wallace   +7 more
openaire   +2 more sources

Real‐Time PCR Duplex Assay for Rickettsia prowazekii and Borrelia recurrentis

Annals of the New York Academy of Sciences, 2003
Abstract: Rickettsia prowazekii, the etiologic agent for epidemic typhus, and Borrelia recurrentis, the etiologic agent of relapsing fever, both utilize the same vector, the human body louse (Pediculus humanus), to transmit human disease. We have developed an assay to detect both bacterial pathogens in a single tube utilizing real‐time PCR.
Ju, Jiang, Joseph J, Temenak, Allen L, Richards   +2 more
openaire   +2 more sources

Borrelia recurrentis Infection: Single-Dose Antibiotic Regimens and Management of the Jarisch-Herxheimer Reaction

Journal of Infectious Diseases, 1978
For evaluation of single-dose antibiotic regimens in treatment of infection due to Borrelia recurrentis, 51 patients with louse-borne relapsing fever were randomly assigned either to one of two orally administered antibiotic regimens (500 mg of tetracycline or erythromycin) or to one of two parenterally administered regimens (250 mg of tetracycline ...
T, Butler, P K, Jones, C K, Wallace
openaire   +2 more sources

Possible Prevention of Tick-Borne Relapsing Fever in Patients Infected with Borrelia recurrentis

Journal of Infectious Diseases, 1984
COLLEAGUESSome areas in the northern part of the Israel desert (Negev) are known to be endemic for Borrelia recurrentis infection [1] (tick-borne relapsing fever). Four groups of subjects, aged 18-21 years, had an overnight stay in a few caves along a small valley in this area. The groups camped separately overnight in the same caves within an interval
E. Galun, E. Ben-Cretrit
openaire   +1 more source

Bioactive phytocompounds against specific target proteins of Borrelia recurrentis responsible for louse-borne relapsing fever: Genomics and structural bioinformatics evidence

Medical and Veterinary Entomology, 2023
Anand Anbarasu, Soumya Basu
exaly  

Conceptualizing histories of multispecies entanglements: Ancient pathogen genomics and the case of Borrelia recurrentis

Journal of Social Archaeology, 2021
Venla Oikkonen
exaly  

Ganz-Genom Sequenzierung verschiedener Borrelia recurrentis Stämme

Das Gesundheitswesen, 2016
D Marosevic, V Fingerle, C Hizo-Teufel, S Stockmeier, A Wieser, A Sing, G Margos   +6 more
openaire   +1 more source

Borrelia recurrentis

2016
openaire   +1 more source

Borrelia recurrentis

2006
openaire   +1 more source